Literature DB >> 3022114

Serum antibodies to individual cytomegalovirus structural polypeptides in renal transplant recipients during viral infection.

M P Landini, G Mirolo, P Coppolecchia, M C Re, M La Placa.   

Abstract

In a longitudinal study we examined by immunoblotting (IB) the development and the evolution of the humoral immune response against individual cytomegalovirus (CMV) structural polypeptides in a total of 80 serum samples from 13 renal transplant recipients showing serological evidence of CMV infection and five renal transplant recipients with an anti-CMV antibody level unchanged over the observation period. The results showed that the IB reactivity at the time of transplantation may be a good index of the host's humoral immune status against CMV; by using this procedure it is possible to identify a seroconversion by the detection of antibodies reacting with some intermediate molecular weight proteins in sera examined at high dilution. Furthermore, IB is a very sensitive procedure also for IgM detection as it anticipates the positivity of the enzyme immune assay for IgM.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3022114     DOI: 10.1111/j.1348-0421.1986.tb02994.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  12 in total

1.  Comparison of four techniques for detection of antibodies to cytomegalovirus.

Authors:  Y J Kraat; R M Hendrix; M P Landini; C A Bruggeman
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

2.  Human cytomegalovirus structural proteins: immune reaction against pp150 synthetic peptides.

Authors:  M P Landini; A Ripalti; K Sra; P Pouletty
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

3.  Evaluation of four methods for cytomegalovirus antibody detection for use by a bone marrow transplantation service.

Authors:  D S Leland; K A Barth; E B Cunningham; J Jansen; G J Tricot; M L French
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948

4.  Antibody response to individual cytomegalovirus structural proteins in different groups of subjects.

Authors:  G Mirolo; B Baldassarri; A Ripalti; M C Re; M Clementi; A Manzin; M P Landini
Journal:  Eur J Clin Microbiol       Date:  1987-04       Impact factor: 3.267

5.  Comparative sequence analysis of human cytomegalovirus strains.

Authors:  R Lehner; T Stamminger; M Mach
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

6.  Diagnostic value of monitoring human cytomegalovirus late pp67 mRNA expression in renal-allograft recipients by nucleic acid sequence-based amplification.

Authors:  M J Blok; V J Goossens; S J Vanherle; B Top; N Tacken; J M Middeldorp; M H Christiaans; J P van Hooff; C A Bruggeman
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

7.  Antibody response to recombinant lambda gt11 fusion proteins in cytomegalovirus infection.

Authors:  M P Landini; T Lazzarotto; A Ripalti; M X Guan; M La Placa
Journal:  J Clin Microbiol       Date:  1989-10       Impact factor: 5.948

8.  Site-specific glycosylation of the human cytomegalovirus tegument basic phosphoprotein (UL32) at serine 921 and serine 952.

Authors:  K D Greis; W Gibson; G W Hart
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

Review 9.  Humoral immune response to human cytomegalovirus infection: diagnostic potential of immunoglobulin class and IgG subclass antibody response to human cytomegalovirus early and late antigens.

Authors:  B Weber; W Braun; J Cinatl; H W Doerr
Journal:  Clin Investig       Date:  1993-04

10.  Identification and procaryotic expression of the gene coding for the highly immunogenic 28-kilodalton structural phosphoprotein (pp28) of human cytomegalovirus.

Authors:  H Meyer; A T Bankier; M P Landini; C M Brown; B G Barrell; B Rüger; M Mach
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.